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Abstract
Background: Inducible high-level expression is favoured for recombinant protein production in Pichia pastoris.
Therefore, novel regulated promoters are desired, ideally repressing heterologous gene expression during initial
growth and enabling it in the production phase. In a typical large scale fed-batch culture repression is desired
during the batch phase where cells grow on a surplus of e.g. glycerol, while heterologous gene expression should
be active in the feed phase under carbon (e.g. glucose) limitation.
Results: DNA microarray analysis of P. pastoris wild type cells growing in glycerol-based batch and glucose-based
fed batch was used for the identification of genes with both, strong repression on glycerol and high-level
expression in the feed phase. Six novel glucose-limit inducible promoters were successfully applied to express the
intracellular reporter eGFP. The highest expression levels together with strong repression in pre-culture were
achieved with the novel promoters PG1 and PG6.
Human serum albumin (HSA) was used to characterize the promoters with an industrially relevant secreted protein.
A PG1 clone with two gene copies reached about 230% of the biomass specific HSA titer in glucose-based fed
batch fermentation compared to a PGAP clone with identical gene copy number, while PG6 only achieved 39%. Two
clones each carrying eleven gene copies, expressing HSA under control of PG1 and PG6 respectively were generated
by post-transformational vector amplification. They produced about 1.0 and 0.7 g L-1 HSA respectively in equal fed
batch processes. The suitability in production processes was also verified with HyHEL antibody Fab fragment for PG1
and with porcine carboxypeptidase B for PG6. Moreover, the molecular function of the gene under the control of
PG1 was determined to encode a high-affinity glucose transporter and named GTH1.
Conclusions: A set of novel regulated promoters, enabling induction without methanol, was successfully identified
by using DNA microarrays and shown to be suitable for high level expression of recombinant proteins in
glucose-based protein production processes.
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Background
The methylotrophic yeast Pichia pastoris is widely used
as a production platform for heterologous proteins.
Latest developments in strain engineering for improved
protein folding and secretion and glyco-engineering have
recently been reviewed by Damasceno et al. [1].
Another important target for strain development is
the promoter driving expression of the heterologous gene.
A summary of the most important promoters of non-
methylotrophic and methylotrophic yeasts is provided
by Mattanovich et al. [2]. While production of recombin-
ant proteins in P. pastoris has been successfully achieved
under control of the constitutive glyceraldehyde-3-
phosphate dehydrogenase promoter (PGAP), regulated
promoters have several advantages: they enable initial
biomass gain without product formation and allow tuning
of the production process. Additionally, a potential impact
of product accumulation on growth or viability of the cells
can be prevented by decoupling growth from the
production phase.
However, today’s available regulated promoters of
P. pastoris have drawbacks. Many of them derive from
methanol utilization pathway genes, which are generally
repressed by glucose and/or ethanol and strongly induced
by methanol. PAOX1 induces high-level expression of its
encoded alcohol oxidase 1, which catalyzes the oxidation
of methanol to formaldehyde [3]. Its weaker homolog
PAOX2 has been used for protein production as well [4].
Another strong promoter of this pathway is PFLD1, its gene
formaldehyde dehydrogenase is either induced by methyl-
amine or methanol [5]. The promoter of dihydroxyacetone
synthase, PDAS, was reported to be similarly regulated and
even stronger than PAOX1 [3], however it is not com-
monly used for protein production. Methanol and
methylamine are both highly flammable and hazardous
to health, so safety precautions are required for their
industrial use. In addition to that, methanol consump-
tion is technically disadvantageous because it causes
high heat evolution and an increased oxygen demand
during the fed batch phase [6].
The PICL1 promoter controls the expression of isocitrate
lyase and is regulated by the carbon source used for cell
growth. No detectable promoter activity is present when
cells are growing on glucose, while it gets turned on when
cells are stationary or growing on ethanol [7]. Hence, this
promoter might be an alternative for some applications,
but its regulatory properties are poor. PHO89 is a regu-
lated sodium phosphate symporter and its promoter was
investigated and shown to produce reasonable amounts of
protein [8]. Cells must be phosphate-limited for the full
activation of PPHO89, and an increase in product titer was
even shown in phosphate-limited stationary phase. Add-
itionally, an impact on growth was reported and reduced
cellular fitness can be assumed in these conditions.
On the other hand, constitutive promoters might be
advantageous for the over-expression of genes or to
co-express helper factors and marker genes. The
widely-used PGAP controls the expression of glyceral-
dehyde-3-phosphate dehydrogenase at a high basal
level [9]. Its productivity can be influenced by control-
ling the growth rate at the optimal activity of PGAP
[10], and by a decrease of available O2 levels [11]. The
promoter of the translational elongation factor EF-1
alpha gene, PTEF1, was analyzed and showed a tighter
growth-associated regulation than PGAP [12].
A promoter library of PAOX1 was generated, leading to
a few variants that were slightly stronger than wild type
PAOX1, and a number of variants with altered regulatory
properties, some of them being active without methanol
[13]. Another library approach was done for PGAP by
mutation and clones expressing yeast-enhanced green
fluorescent protein (yEGFP) under the control of
obtained variants produced 8 to 218% of fluorescence in-
tensity compared to the wild type promoter [14].
Potential promoter libraries can also be deduced from
microarray data and rational considerations. Focussing
on highly transcribed genes in general, 15 promoters
were selected for characterization and the promoter of
the thiamine biosynthesis gene PTHI11, which is regulated
by the availability of thiamine in the growth medium,
was discovered [15].
As described above, the number of strong promoters
with advantageous properties for protein production is
limited in P. pastoris. This work was designated to
identify novel promoters with both, high expression and
an optimal regulation in production process conditions.
Equally important, the addition of inducers was to be
avoided, because their use is often associated with extra
costs and safety precautions in large scale fermentation
processes.
A typical production process under the control of
PGAP uses glycerol in the batch phase, and a constant
glucose fed batch for 100 hours to reach more than 100
g L-1 cell dry weight [16]. In order to identify potential
inducible promoters in the course of this process, we
used DNA microarray analysis to compare gene expres-
sion patterns of glycerol-excess (=batch growth phase)
and glucose-limited (=fed batch production phase) con-
ditions. The expression capacity of selected promoter
targets was characterized with model proteins and veri-
fied in fed batch processes.
Results and discussion
Identification of novel promoters with desired induction
properties
A typical P. pastoris protein production process avoiding
methanol induction starts with a glycerol batch (surplus
of carbon source) which is followed by a glucose fed
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batch (limit of carbon source) [10]. DNA microarrays
were used to analyze gene expression patterns and to
identify potential promoters for this cultivation strategy.
In order to eliminate growth rate related effects, glucose-
limited conditions were analyzed in chemostat cultivation
where the growth rate, similar to that in the batch phase,
was fixed by controlling the dilution rate at 0.1 h-1.
The microarray data was mined for genes with both,
high difference in expression level between repressed
and induced state (fold change) as well as high signal in-
tensity in the induced state to identify potent promoters
for inducible high-level protein production in P. pastoris.
Six potential promoters (abbreviated as PG1, PG3, PG4,
PG6, PG7 and PG8, see Figure 1 and Table 1) were consid-
ered for further characterization.
Verification of promoter strength and regulation
At first, the strength and regulation of the novel promo-
ters were assayed with the intracellular reporter protein
eGFP in small scale screening cultures. Both, repressive
conditions in pre-culture (glycerol excess) and induced
ones during main culture (glucose limit) were analyzed
during the screening. In order to simulate fed batch like
conditions in screenings, we had to adapt the screening
strategy. Instead of usual feedings with certain amounts
of glucose which lead to repeated batch phases, we used
slow glucose releasing polymer particles (12mm feed
beads, Kuhner, CH), liberating glucose at a non-linear
rate of 1.63 ∙ t0.74 mg per disc (t = time [h]), which
equals to 28.6 mg per disc after 48 hours.
As shown in Figure 2, PG1 and PG6 had superior prop-
erties in terms of both, regulation and induction
strength. In order to visualize gene dosage effects, gen-
omic DNA of several clones was isolated and analyzed
by real-time PCR to determine the gene copy number
(GCN) of eGFP. Compared to a PGAP clone with one
gene copy, the specific fluorescence of PG1 and PG6
controlled expression of eGFP (normalized to GCN)
were induced from almost zero in batch phase to about
150% and 100% after 48 h screening culture, respect-
ively. The other promoters PG3, PG4, PG7, and PG8 still
showed a good regulation and induction strength suit-
able for inducible protein expression, with expression
strengths spanning a spectrum of about 20% to 120%
relative to PGAP (Figure 2A). The next step was to inves-
tigate the induction behaviour of the novel promoters in
more detail.
Analysis of the glucose dependent regulation
The induction behaviour of the novel promoters was
characterized in screenings with eGFP producing clones
in YP media containing different amounts of glucose
(ranging from 20 to 0.002 g L-1). The cells were culti-
vated for 5–6 hours and eGFP expression was analyzed
by flow cytometry.
Promoters PG1 and PG7 showed a flat induction course
leading to full activity only with less than 0.05 g L-1 glu-
cose. That is clearly different to PG3, PG4 and PG6´s stee-
per regulation pattern which reach their top activity
already at around 4 g L-1 glucose (Figure 3). In other
words, PG1 is not only the strongest but also most tightly
repressed by glucose among the promoters tested here.
Based on these regulatory features we intended to
characterize the functions of the genes under control
of the PG promoters. At the time of their identifica-
tion, no or only putative functions were assigned to
the underlying genes aside from G1. Therefore, we
used NCBI Conserved Domain search to analyze the
protein sequences in order to identify putative gene
functions.
The gene under the control of PG1 was previously
functionally clustered with K. lactis high-affinity glucose
transporter HGT1 [17]. It contains two major facilitator
superfamily domains, same as the G7 gene, which is
therefore assumed to be a glucose transporter too. For
Saccharomyces cerevisiae, it was reported that hexose
transporters underlie complex regulation patterns and
are expressed in dependence of glucose concentration
[18]. The regulation pattern exhibited by the promoters
Figure 1 Microarray data (red channel) of identified target
genes in comparison to GAP. Bars represent relative expression
levels in glycerol excess (batch phase, blue bars on the left side) and
in glucose limit (chemostat cultivation, red bars on the right side).
Numbers in the right column represent the fold change of signal
intensity between glucose limit and glycerol excess conditions.
Table 1 Identified promoter candidates
Promoter Gene P. pastoris gene identifier (strain GS115)
PGAP GAP PAS_chr2-1_0437
PG1 G1 PAS_chr1-3_0011
PG3 G3 PAS_chr4_0550
PG4 G4 PAS_chr4_0043
PG6 G6 PAS_chr2-1_0853
PG7 G7 PAS_chr1-4_0570
PG8 G8 PAS_chr1-3_0165
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PG3, PG4, PG6 and PG8 might be associated with a role in
central metabolism. An AKR (aldo keto reductase) do-
main was found in the gene expressed under PG3. The
genes controlled by PG4 and PG6 are both putative
aldehyde dehydrogenases, predicted to be localized in
the cytosol and in the mitochondria, respectively. The
Gti1/Pac2 family domain found in G8 plays a role in
gluconate uptake upon glucose starvation and in sexual
development in Schizosaccharomyces pombe.
We could show the need of an explicit glucose limit
for full activity of the novel promoters, which is most
pronounced for PG1. This demonstrates that the micro-
array data-based promoter selection is excellently suited
to select for promoters with features relevant for biopro-
cesses, and secondly indicates the novel promoter´s
advantages in fed batch fermentation.
To prove this statement, the application of the strongest
and most promising promoter PG1 was tested in a fed
batch fermentation where truly glucose-limited conditions
are present [10]. A single gene copy clone expressing
eGFP was chosen for comparison to an equivalent single
gene copy clone of eGFP under the control of PGAP.
Thereby we could show that the PG1 promoter remains
repressed during the batch phase and that its induction
during fed batch clearly exceeds the strength of PGAP.
Relative eGFP expression (fluorescence related to the
culture volume) and OD600 over the feed time are shown
in Figure 2B.
Expression of secreted human serum albumin
PG1 and PG6 were further selected to assay the produc-
tion of a secreted protein under their control. Human
serum albumin (HSA) is efficiently produced in P. pas-
toris. Therefore it can be regarded as an industrially
relevant secreted reporter protein. Its expression under
the control of PG1, PG6 and PGAP was screened in shake
flasks with glucose-limited conditions (through the use
of feed beads) in the main culture. During the glycerol
(batch) pre-culture, both PG1 and PG6 promoters remained
well repressed. As seen before, during main culture expres-
sion under PG1 was stronger than under PG6 and, in rela-
tion to gene copy number, reached around 77% of the
biomass specific HSA yield of cells expressing under PGAP,
while PG6 produced about 22% of PGAP (Figure 4A). How-
ever, the novel promoters might not show their full poten-
tial in shake flask screenings, since these conditions are not
strictly glucose limited during the entire production phase.
To exploit the full potential of the novel promoters, glu-
cose limited fed batch cultivations were performed. Based
Figure 2 Expression of eGFP under control of the novel
promoters PG1, PG3, PG4, PG6, PG7 and PG8. (A) Specific eGFP
fluorescence in shake flask screenings related to PGAP and to eGFP
gene copy number. (B) Fed batch cultivations of single gene copy
clones expressing eGFP under the control of PGAP and PG1. Relative
eGFP expression (solid lines) and OD600 (dashed lines) are shown
over the feed time.
Figure 3 Induction behaviour of the novel promoters. Specific
eGFP fluorescence of clones expressing eGFP under the control of
PG1, PG3, PG4, PG6 and PG7 in media containing different amounts of
glucose. Data is related to PGAP, normalized to 1.0 at the highest
glucose concentration of 20 g L-1 and plotted against the
logarithmic glucose concentration (trend line calculation: four
parameter logistic curve). The glucose concentration given on the x-
axis refers to the glucose set point at the beginning of the
cultivation (serial dilutions ranging from 20 to 0.002 g L-1). This
screening setup and data processing points out relative promoter
activities, thereby showing the kinetics of induction, but does not
allow comparison of promoter strength.
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on the screening results, one clone each expressing suffi-
cient amounts of HSA under the control of PG1 and PG6
was selected. Those clones, harbouring two and one gene
copies respectively, were compared with their respective
gene copy equivalent PGAP clones (Figure 4B, 4C and 4D).
Dry cell weight (DCW) and HSA titers are summarized in
Table 2. HSA titers of PGAP clones correlate with their re-
spective gene copy number. Again, the PG1 clone showed
superior properties - it clearly outperformed the PGAP clone
with the same gene copy number and produced about
230% of the biomass specific product yield compared to
PGAP. PG6 produced about 39% of the biomass specific
HSA yield of its gene copy equivalent PGAP clone. Besides,
PGAP-driven expression was already active in the batch
phase, and more than 5% of the final HSA amount was
already present at the batch end for both clones expressing
under its control. While this is not an issue in case of HSA,
it is a clear disadvantage compared to inducible promoters
such as PG1 in case of toxic or difficult to express products.
Figure 4C shows HSA titer over the feed time, and the
unique repression/induction efficiency of PG1 is clearly
pointed out in the first hours (Figure 4D). Both, PG1 and
PG6 showed good repression in the batch phase and induc-
tion by the glucose limited feed.
To verify that the novel promoters also exhibit their
superior regulatory properties and expression capacity
Figure 4 Expression of secreted HSA using the novel promoters PG1 and PG6 in shake flask and fed batch cultivations. (A) HSA
expression in shake flask screenings related to PGAP and to the gene copy number. (B) Dry cell weight and (C) HSA titer in fed batch cultivations
of double and single gene copy clones expressing under the control of PG1 (circle, two copies), PG6 (diamond, one copy) and PGAP (black square,
two copies and black-and-white, one copy). (D) Detail of (C) showing late batch and early fed batch phase, highlighting the different regulation
properties of the promoters. Except for the single gene copy PGAP clone, all fermentations were performed in duplicates.
Table 2 Summary of fed batch cultivations of P. pastoris expressing HSA under the control of PG1, PG6 and PGAP
Batch end Fed batch end
Promoter GCN DCW HSA HSA/DCW DCW HSA HSA/DCW % HSA/DCW
[g L-1] [mg L-1] [mg g-1] [g L-1] [mg L-1] [mg g-1] of PGAP
PG1* 2 24.3 0.5 0.0 126.9 303.1 2.4 231.2
PG6* 1 23.9 0.3 0.0 127.1 24.3 0.2 38.9
PGAP* 2 23.8 10.1 0.4 123.7 128.2 1.0
PGAP 1 24.2 5.0 0.2 117.7 57.8 0.5
* performed in duplicates.
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in industrially relevant conditions, we elevated HSA
gene copy number by post-transformational vector
amplification as described previously [19]. Thereby,
we were able to produce more than 1 g L-1 HSA
under the control of PG1 with a clone harbouring 11
gene copies, which corresponds to the 3.4-fold titer
of its two copy clone (Table 3). Again, PG1 outper-
formed a comparable clone with the same gene copy
number under the control of the PGAP promoter,
which produced 607 mg L-1 HSA in a similar fermen-
tation [19]. High level HSA production was also
achieved with an amplified clone expressing HSA (11
gene copies as well) under the control of the weaker
PG6 promoter, which produced more than 720 mg L
-1
HSA (Table 3). This titer is approximately 30-fold
higher than the titer reached with the PG6 single copy
clone (24 mg L-1), thus indicating that multiple copies
of expression cassettes under control of a weaker pro-
moter can also lead to high productivities. One
possible explanation of this effect could be that the ratio
of a repressing protein to promoter copy number and
thus repressor binding sites is decreased in the ampli-
fied clones, therefore leading to higher transcription.
Additionally, the porcine enzyme carboxypeptidase
B (CpB) that is used for human insulin production, and an
antibody Fab fragment were produced under the
control of PG1 and PG6 respectively, and exceeded the
production levels compared to PGAP. Thereby we verified
again the suitability of these promoters in standard
glucose based production processes.
PG1 activity depends on specific growth rate
We elucidated the expression activity of PG1 at different
growth rates using an HSA clone with two gene copies
under its control. It was cultivated in chemostat with
different dilution rates and the highest specific product
formation was found at a growth rate of about 0.07 h-1
(Figure 5). This clearly differs to the profile obtained
with PGAP in [10], where the highest specific product
formation was obtained only at higher growth rates.
Growth rate dependency may be utilized to optimize
space-time yield or other parameters in the production
processes [10].
Knock out of G1
Furthermore, we decided to clarify the function of the gene
PAS_chr1-3_0011, which underlies the control of the
promoter PG1. It contains 12 transmembrane domains
(predicted by TMHMM Server v. 2.0), two Major Facilita-
tor Superfamily (MFS) and other transporter domains.
Based on the sequence homology to the K. lactis high-
affinity glucose transporter HGT1, the gene controlled by
PG1 was expected to have a function in glucose transport
[17], [20]. Strong activity of its promoter at very low glucose
concentrations further strengthened this assumption. For
further verification, the gene was disrupted using the split
marker cassette technique (primers given in Additional file
1: Table S1) as described by Heiss et al. [21]. Similar as
described by Jørgensen and his colleagues [22], we com-
pared the glucose uptake of the wild type and a G1 knock
out clone in glucose-limited chemostat cultivations at dif-
ferent growth rates. The glucose saturation constants were
calculated from the residual glucose concentrations
(Table 4) and a KS of 9.7, 23.1 and 69.3 μM was obtained
for three different dilution rates (μ=0.14, 0.1 and 0.05 h-1)
for the wild type. Changing KS values are observed for the
whole cell in different conditions, which is due to the differ-
ential regulation of its several transporters. A reduced
Table 3 Summary of fed batch cultivations of GCN amplified HSA expressing clones under the control of PG1 and PG6
Batch end Fed batch end
Promoter GCN DCW HSA HSA/DCW DCW HSA HSA/DCW
[g L-1] [mg L-1] [mg g-1] [g L-1] [mg L-1] [mg g-1]
PG1 11 18.9 0.2 0.0 114.0 1060.8 9.3
PG6* 11 22.5 0.3 0.0 110.8 728.7 6.6
* performed in duplicates.
Figure 5 Correlation of specific productivity to specific growth
rate using PG1. Specific product formation rate (qp) observed in
chemostat cultivation at different dilution rates of a clone expressing
HSA under the control of PG1 as well as the respective trend curve
(spline curve).
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capacity of glucose uptake at low specific growth rates has
been reported before [22]. The G1 knock out clone
appeared to have much higher saturation constants of 90.4,
99.0 and 207.8 μM at the same dilution rates, which was
also described for the high-affinity glucose transporter dis-
ruption in Aspergillus niger [22]. The knock out clone does
not display the low KS values of the wild type, so that the
gene PAS_chr1-3_0011 was clearly identified as a high-
affinity glucose transporter. As the short name HGT1 is
used as an alias for a peptide transporter in S. cerevisiae we
suggest the short name GTH1 (glucose transporter with
high affinity) for this P. pastoris gene.
Conclusions
Efficient regulated promoters cannot necessarily be
found by classical batch screening approaches. Simulat-
ing production conditions in lab scale and searching the
promoter space offers a new target oriented approach.
We could show here that the cultivation of P. pastoris in
conditions where repression or induction are desired,
followed by the analysis of transcript levels with DNA
microarrays offers a potent opportunity to find new,
strong and regulated promoters.
Six novel promoters were identified and further charac-
terized. All of them are activated by carbon source deple-
tion. The new promoters provide a tool box for
expression of recombinant genes and are thus well suit-
able for protein production processes. PG1 had the most
favourable repression kinetics and exceeded the expres-
sion levels of the well-established constitutive GAP pro-
moter in glucose limited fed batch cultures by more than
twofold. The molecular function of the gene under its
control was identified as high-affinity glucose transporter
and named GTH1.
Materials and methods
Strains and cultivation
Escherichia coli DH10B (Invitrogen) was used for
subcloning. It was routinely cultivated in petri dishes or
shake flasks using LB media supplemented with 25 μg
mL-1 Zeocin. A wild type Pichia pastoris strain
CBS2612 which can grow on minimal media supple-
mented with biotin, was used for protein expression in
this work.
The main culture for screenings was either done with YP
or BM media and glucose feed beads (12 mm, Kuhner, CH)
which provided the carbon source.
YP media contained 20 g L-1 peptone and 10 g L-1
yeast extract, which can be supplemented with 12.6 g
glycerol or 20 g glucose to obtain YPG and YPD,
respectively. For cultivation on plates, 5 g L-1 agar-agar
was added to the liquid medium. BM media was based
on YP, supplemented with 13.4 g L-1 yeast nitrogen base
(Cat.No. 291940, Becton Dickinson, FR) with ammo-
nium sulfate, 0.4 mg L-1 biotin and 100 mM potassium
phosphate buffer pH 6.0.
Identification of novel inducible promoters
a) Bioreactor cultivations
Fermentations for the identification of promoter
candidates were done in 3.5 L working volume
bioreactors (Minifors, Infors, CH) in three biological
replicates. Cells were grown for about 24 h in batch on
glycerol medium, followed by an exponential feed phase
on glycerol fed batch medium calculated as described by
Resina et al. [23] with a specific growth rate of μ= 0.1 h-1
and a substrate yield coefficient of YX/S of 0.5 g g
-1.
Sequentially, chemostat cultivation (D = μ = 0.1 h-1)
with high density glucose medium was performed.
Glycerol batch medium contained per liter: 2 g citric
acid monohydrate, 39.2 g glycerol, 20.8 g NH4H2PO4,
0.5 g MgSO4∙ 7H2O, 1.6 g KCl, 0.022 g CaCl2∙ 2H2O,
0.8 mg biotin and 4.6 mL PTM1 trace salts stock
solution. HCl was added to set the pH to 5.0.
Glycerol fed-batch medium contained per liter: 632 g
glycerol, 8 g MgSO4∙ 7H2O, 22 g KCl, and 0.058 g
CaCl2∙ 2H2O.
High-density chemostat medium contained per liter: 2 g
citric acid monohydrate, 99.42 g glucose monohydrate,
22 g NH4H2PO4, 1.3 g MgSO4∙ 7H2O, 3.4 g KCl, 0.02 g
CaCl2∙ 2H2O, 0.4 mg biotin and 3.2 mL PTM1 trace
salts stock solution. HCl was added to set the pH to 5.0.
PTM1 trace salts stock solution contained per liter:
6.0 g CuSO4∙ 5H2O, 0.08 g NaI, 3.36 g MnSO4∙
H2O, 0.2 g Na2MoO4∙ 2H2O, 0.02 g H3BO3, 0.82 g
CoCl2, 20.0 g ZnCl2, 65.0 g FeSO4∙ 7H2O, 0.2 g
biotin and 5.0 mL H2SO4 (95%-98%).
b) Microarray hybridization
RNA purification and sample preparation as well as
microarray hybridization (in-house designed P. pastoris
specific oligonucleotide arrays, AMAD-ID: 034821,
8x15K custom arrays, Agilent) and data analysis were
done as described by Graf et al. [24].
Table 4 Glucose substrate saturation constants of a
wildtype and a G1 knock out clone
G1 k. o., μmax = 0.18 h
-1 Wildtype, μmax = 0.18 h
-1
D [h-1] S [μM] X [g L-1] KS [μM] S [μM] X [g L
-1] KS [μM]
0.14 316.4 29.5 90.4 33.9 30.5 9.7
0.10 123.8 31.3 99.0 28.9 32.1 23.1
0.05 79.9 31.3 207.8 26.6 30.8 69.3
Residual glucose (S), dry cell weight (X) and substrate saturation constant (KS)
of a wild type and a G1 knock out (k. o.) clone at different dilution rates in
chemostat cultivations.
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Characterization of promoter strength and regulation
a) Cloning
Cloning and transformation was done using the in-
house vector pPuzzle [15], which contains a Zeocin
resistance cassette for selection in both E. coli and
yeast, an expression cassette for the gene of interest
(GOI) consisting of a multiple cloning site and the
S. cerevisiae CYC1 transcription terminator, and a
locus for integration into the P. pastoris genome
(3´ AOX1 region or rDNA locus). Promoter
sequences (up to 1000 bps upstream of the start
codon of their respective genes) were PCR-amplified
from P. pastoris genomic DNA (primer sequences
see Additional file 1: Table S1). The promoters were
ligated into pPuzzle in front of the start codons of the
model proteins, using the ApaI and the SbfI
restriction sites of the multiple cloning site of the
vector. Vectors expressing the respective model protein
under control of PGAP were used as controls
throughout the study. For the expression of
heterodimeric HyHEL antibody Fab fragment (HyHEL
Fab), the expression cassettes of light chain and Fab
heavy chain (each under control of PG1) were combined
into one vector (using the strategy described in [27]).
HSA was secreted by its native secretion leader,
while for CpB and HyHEL Fab the S. cerevisiae alpha
mating factor signal sequence was used. To avoid
positional effects on reporter gene expression levels,
genome integration of the expression plasmids was
targeted to either the 3´flanking region of the AOX1
gene or the ribosomal DNA locus (rDNA, for
multicopy integration) of P. pastoris, respectively.
Plasmids were linearized within the genome integration
region prior to electroporation (2 kV, 4 ms, GenePulser,
BioRad) into electrocompetent P. pastoris. Multicopy
integration of HSA expressing clones was done as
described by Marx et al. [19] and selected at higher
Zeocin concentrations (up to 1000 μg mL-1).
P. pastoris cells were first selected and cultivated in
petri dishes on YPD agar and then inoculated in an
YPG medium as pre-culture for screenings and
fermentations. Antibiotic selection by Zeocin was
applied on plates and in pre-culture at a concentration
of 25 μg mL-1 or higher.
b)Expression screening
Expression of intracellular eGFP and the secreted
proteins HSA, CpB and HyHEL Fab with the novel
promoters in comparison to PGAP was evaluated in shake
flask screenings. All screenings were performed at 25°C
and with shaking at 180 rpm. Single colonies were
inoculated in YPG medium with selection pressure
(Zeocin) for pre-culture. After approximately 24 hours,
the pre-culture was used to inoculate the main culture
with an optical density (OD600) of 0.1 (for eGFP) or 1
(for HSA, CpB and HyHEL Fab) in 10 mL YP or BM
medium, respectively. Glucose feed beads (12 mm,
Kuhner, CH) were used to generate glucose-limiting
growth conditions. Expression of eGFP was measured at
the end of pre-culture and at 24 and 48 hours of the
main culture. Culture supernatant of clones expressing
secreted protein was harvested from the pre-culture and
after 48 hours and cell density was determined by
measuring wet cell weight or OD600.
c) Comparative analysis of P. pastoris promoter activity
In order to analyze relative transcription strength of
the PG promoters at different glucose concentrations, a
comparative promoter activity study using various
glucose concentrations (ranging from 20 to 0.002 g L-1
glucose) was performed with eGFP expressing clones
in 24-well plates (Cat. No. 7701–5110, Whatman, UK)
covered with breath seal membranes (Cat. No. B-100,
Excel Scientific, CA). Glucose concentrations of 20, 10,
5, 2.5, 1.25, 0.63, 0.31, 0.16, 0.08, 0.04, 0.02, 0.01, 0.005,
0.002 g L-1 were obtained by serial dilution in YP
media, and represent the inital setpoints. The main
culture was inoculated from YPG-Zeocin pre-culture
with an OD600 of 0.01 and samples were taken after
5–6 hours and analyzed by flow cytometry.
d)Fed batch cultivation
All fed batch fermentations were done in 1.0 L working
volume bioreactors (SR0700ODLS, DASGIP, DE). The
dissolved oxygen was controlled at DO = 20% with the
stirrer speed (400 – 1200 rpm). Aeration rate was 18 L
h-1 air, the temperature was controlled at 25°C and the
pH was controlled at 5.85 for HSA [25] or pH 5.0 for
the other proteins [10] with addition of ammonium
hydroxide (25%). To start the fermentation, 300 mL
batch medium was sterile filtered into the fermenter
and a P. pastoris clone was inoculated from an
overnight pre-culture with a starting optical density
(OD600) of 1. For the cultivation of clones expressing
eGFP, the batch phase of approximately 25 h was
followed by a fed batch phase with a feeding rate
optimized according to [10]. HSA expressing strains
were cultivated as described by Marx et al. [19], where
the batch phase was followed by a constant feed of 2 g
h-1 fed batch medium for 100 h, Carboxypeptidase B
and HyHEL Fab expressing clones were cultivated
similarly. Samples were taken during batch and fed
batch phase, and analyzed for expression.
Glycerol batch and glucose fed batch media for eGFP,
HyHEL Fab and Carboxypeptidase B expressing
clones were exactly as described in [10], while for the
production of HSA the media was described in [19].
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e) Chemostat cultivation
A strain expressing HSA (2 GCN) under control of
PG1 was tested for its growth rate dependent
expression behaviour in chemostat at different dilution
rates (D = 0.03, 0.06, 0.10, 0.13) [10].
For characterization of glucose uptake characteristics,
the P. pastoris wild type strain and the strain deleted
for PAS_chr1-3_0011 were cultivated in glucose
limited chemostats at D = 0.05, 0.10, and 0.14 h-1.
Samples were taken rapidly as described below.
Analytical methods
a) Copy number determination with real-time PCR
Genomic DNA was isolated using the DNeasy
Blood&Tissue Kit (Cat. No. 69504, Quiagen, DE).
Gene copy numbers were determined with quantitative
PCR using the SensiMix SYBR Kit (QT605-05, Bioline
reagents, UK). The primers (supplementary Additional
file 1: Table S1) and sample were mixed with the
SensiMix and applied for real time analysis in a real-
time PCR cycler (Rotor Gene, Qiagen, DE). All
samples were analyzed in tri- or quadruplicates. Data
analysis was performed with the two standard curve
method of the Rotor Gene software. The actin gene
ACT1 was used as calibrator.
b)Determination of protein expression levels
A plate reader (Infinite 200, Tecan, CH) was used to
determine eGFP fluorescence in fermentation
samples. Therefore, samples were diluted to an OD600
of 5 and fluorescence intensity was then related to
the culture volume.
Expression of eGFP in screenings was analyzed by
flow cytometry as described before [15]. Specific
eGFP fluorescence referred to in this study is the
fluorescence intensity related to the cell volume for
each data point as described by Hohenblum et al.
[26]. Then the geometric mean of the population´s
specific fluorescence was normalized by subtracting
background signal (of non-producing P. pastoris wild
type cells) and related to expression under the
control of PGAP.
For quantification of HSA in shake flask and
fermentation supernatants, the Human Albumin
ELISA Quantitation Set (Cat. No. E80-129, Bethyl
Laboratories, TX) was used. The HSA standard was
applied with a starting concentration of 400 ng mL−1.
Dilution-, Blocking- and Washing buffer were based on
TBS (50 mM Tris–HCl, 140 mM NaCl, pH 8.0) and
completed with BSA (1% (w/v)) and/or Tween20
(0.05% (v/v)) accordingly.
HyHEL Fab was determined with ELISA as described
previously [27].
CpB was quantified using an enzymatic assay based
on the cleavage of hippuryl-L-arginine (Cat. No.
H2508, Sigma, MO). Generation of hippuric acid was
monitored at its absorbance maximum of 254 nm.
Prior to the measurement, the samples were desalted
with Zeba Spin columns (Thermo Fisher Scientific,
IL) and activated with trypsin (Cat. No. T8345,
Sigma, MO).
c) Determination of residual glucose
The D-Glucose Assay - GOPOD-Format (Megazymes,
IE) was used to determine residual glucose of chemostat
samples. Supernatant sampling was done by pumping
culture broth out of the bioreactor by producing an
overpressure, and its direct sterile filtration using a
vacuum filter unit (Cat. No. 5141178, Whatman, UK).
Glucose-limited cultivations usually go along with very
low residual glucose concentrations in the supernatant,
so the manufacturer’s protocol was adapted for glucose
concentrations from 10 to 100 mg L-1. Briefly, the
ratio of reaction buffer to sample was changed from
30:1 to 3:1.
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